Episode Player
More Insights from JP Morgan 2026 with Jeff Berkowitz, JD
AVBCC Value-Based Voices
Chapters
1:13
Reflections on JP Morgan Healthcare Conference
9:15
The Absence of Payers
14:04
Direct-to-Patient Models and their Implications
15:50
Government's Role in Healthcare Pricing
19:12
Global Pricing Strategies and Market Access
25:31
The Impact of AI on Healthcare
33:50
Future of Healthcare: Uncertainty and Innovation
AVBCC Value-Based Voices
More Insights from JP Morgan 2026 with Jeff Berkowitz, JD
Feb 07, 2026
Season 1
Episode 2
Rachael
Where was the drama at JP Morgan this year? Host Burt Zweigenhaft, PhD, and seasoned healthcare executive Jeff Berkowitz, JD, debate why the 2026 meeting seemed to be missing its normal electricity. They also share their thoughts around challenges with direct-to-patient models, most-favored-nation and its impact on product launch and pricing both in the US and Europe, and how AI may or may not be the key to finally achieving value-based outcomes.
Contact Value-Based Voices
- Follow AVBCC on LinkedIn
- View our podcast lineup
- Contact us at info@avbcc.org
Thanks for listening!
